SODIUM IODIDE I-131

SODIUM IODIDE I-131 was reported 960 times

SODIUM IODIDE I-131 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ASSISTED REPRODUCTIVE TECHNOLOGY 1 0.5000
1 RADIATION THYROIDITIS 3 0.3000
2 CONGENITAL THYROID DISORDER 1 0.2000
3 DISTURBANCE OF THERMOREGULATION OF NEWBORN 1 0.0769
4 ICTERUS INDEX INCREASED 1 0.0625
5 IODINE UPTAKE DECREASED 1 0.0556
6 MYOSITIS-LIKE SYNDROME 1 0.0556
7 KOILONYCHIA 1 0.0526
8 ULTRASOUND THYROID ABNORMAL 1 0.0417
9 OCCUPATIONAL EXPOSURE TO RADIATION 1 0.0286
10 THYROID CANCER RECURRENT 3 0.0256
11 RADIOISOTOPE UPTAKE INCREASED 1 0.0227
12 METASTASES TO PITUITARY GLAND 1 0.0222
13 POST PROCEDURAL HYPOTHYROIDISM 4 0.0189
14 TOXIC GOITRE 1 0.0164
15 RAOULTELLA ORNITHINOLYTICA INFECTION 1 0.0130
16 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 1 0.0125
17 THYROGLOBULIN INCREASED 2 0.0118
18 ENDOCRINE OPHTHALMOPATHY 10 0.0115
19 AUTOIMMUNE PANCYTOPENIA 1 0.0110
20 DEAFNESS PERMANENT 2 0.0102
21 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 1 0.0098
22 KARYOTYPE ANALYSIS ABNORMAL 1 0.0092
23 CATARACT CORTICAL 1 0.0067
24 LYMPHADENITIS BACTERIAL 1 0.0067
25 VERY LOW DENSITY LIPOPROTEIN INCREASED 1 0.0045
26 MYXOEDEMA 1 0.0045
27 PNEUMONIA MYCOPLASMAL 3 0.0038
28 CHOLANGITIS INFECTIVE 1 0.0038
29 PATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0037
30 CLINODACTYLY 1 0.0036
31 THYROID CANCER METASTATIC 1 0.0036
32 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 3 0.0036
33 MYXOEDEMA COMA 1 0.0033
34 NEONATAL ASPIRATION 1 0.0030
35 CENTRAL HYPOTHYROIDISM 1 0.0030
36 METASTASES TO BREAST 1 0.0030
37 MATERNAL EXPOSURE BEFORE PREGNANCY 20 0.0029
38 BENIGN NEOPLASM OF THYROID GLAND 2 0.0027
39 THYROTOXIC CRISIS 3 0.0026
40 RADIATION OESOPHAGITIS 1 0.0026
41 AZOOSPERMIA 1 0.0026
42 TRI-IODOTHYRONINE INCREASED 1 0.0025
43 PARVOVIRUS INFECTION 1 0.0025
44 INVASIVE BREAST CARCINOMA 1 0.0024
45 VERTEBROPLASTY 1 0.0022
46 OCULAR NEOPLASM 1 0.0021
47 TACHYCARDIA FOETAL 1 0.0020
48 PHYSIOTHERAPY 1 0.0019
49 OVARIAN FAILURE 1 0.0019
50 LARYNGEAL STENOSIS 1 0.0017
51 THYROID CYST 1 0.0017
52 OTOTOXICITY 3 0.0016
53 TRACHEO-OESOPHAGEAL FISTULA 1 0.0016
54 THYROXINE FREE INCREASED 1 0.0016
55 MYELOPROLIFERATIVE NEOPLASM 1 0.0015
56 SIALOADENITIS 2 0.0015
57 THYROXINE INCREASED 1 0.0014
58 OTITIS MEDIA ACUTE 1 0.0014
59 SMALL FIBRE NEUROPATHY 1 0.0014
60 PARATHYROID TUMOUR BENIGN 1 0.0013
61 BASOPHIL COUNT INCREASED 1 0.0013
62 HYPOPARATHYROIDISM 1 0.0013
63 MEAN CELL VOLUME DECREASED 2 0.0013
64 URETERIC STENOSIS 1 0.0012
65 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
66 HEPATIC HAEMORRHAGE 1 0.0012
67 SOLILOQUY 1 0.0012
68 URGE INCONTINENCE 1 0.0011
69 PAPILLARY THYROID CANCER 2 0.0011
70 MUSCLE NECROSIS 1 0.0011
71 CERUMEN IMPACTION 1 0.0011
72 METASTASES TO ADRENALS 1 0.0011
73 PREMATURE MENOPAUSE 1 0.0011
74 DISCOLOURED VOMIT 1 0.0010
75 CROSS SENSITIVITY REACTION 1 0.0010
76 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
77 OPTIC NEUROPATHY 2 0.0009
78 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 1 0.0009
79 FOETAL MALFORMATION 1 0.0009
80 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
81 CARBON DIOXIDE DECREASED 1 0.0009
82 PAROTITIS 1 0.0009
83 MONOCYTE COUNT DECREASED 1 0.0008
84 ACUTE PSYCHOSIS 2 0.0008
85 TRISOMY 21 1 0.0008
86 BILIARY OBSTRUCTION 1 0.0008
87 ENCEPHALITIS AUTOIMMUNE 1 0.0008
88 RED BLOOD CELL COUNT INCREASED 2 0.0007
89 ABORTION 2 0.0007
90 PULMONARY VALVE INCOMPETENCE 1 0.0007
91 NODAL RHYTHM 1 0.0007
92 CONJUNCTIVITIS ALLERGIC 1 0.0007
93 PALLIATIVE CARE 1 0.0007
94 PREMATURE SEPARATION OF PLACENTA 1 0.0006
95 AORTIC VALVE DISEASE 1 0.0006
96 LYMPHOCYTE COUNT INCREASED 2 0.0006
97 DEAFNESS NEUROSENSORY 2 0.0006
98 RECALLED PRODUCT 1 0.0006
99 THYROIDECTOMY 1 0.0006
100 HYPOPITUITARISM 1 0.0006
101 HYPERTHYROIDISM 8 0.0006
102 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
103 HYPERTENSIVE HEART DISEASE 1 0.0005
104 HYPOTHYROIDISM 17 0.0005
105 ATROPHY 1 0.0005
106 EARLY SATIETY 1 0.0005
107 RADIATION PNEUMONITIS 1 0.0005
108 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
109 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
110 HAEMATOCRIT INCREASED 1 0.0004
111 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
112 SINUS PAIN 1 0.0004
113 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
114 GLOMERULONEPHRITIS 1 0.0004
115 MEAN CELL VOLUME INCREASED 1 0.0004
116 PHYSICAL DECONDITIONING 1 0.0004
117 BLOOD CHLORIDE DECREASED 1 0.0004
118 ABDOMINAL MASS 1 0.0004
119 BLOOD SODIUM INCREASED 1 0.0004
120 RASH MORBILLIFORM 1 0.0004
121 FIBULA FRACTURE 1 0.0003
122 LUNG CANCER METASTATIC 1 0.0003
123 ODYNOPHAGIA 2 0.0003
124 FOETAL GROWTH RESTRICTION 2 0.0003
125 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
126 BLOOD CREATININE DECREASED 1 0.0003
127 FOREIGN BODY IN THROAT 1 0.0003
128 ORTHOPNOEA 1 0.0003
129 POSTURE ABNORMAL 1 0.0003
130 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
131 TONGUE ULCERATION 1 0.0003
132 HEPATIC CYST 1 0.0003
133 ONYCHOCLASIS 2 0.0003
134 JAUNDICE CHOLESTATIC 1 0.0003
135 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
136 FACIAL BONES FRACTURE 1 0.0003
137 MONOCYTE COUNT INCREASED 1 0.0003
138 AUTOIMMUNE THYROIDITIS 1 0.0003
139 PARANASAL SINUS DISCOMFORT 1 0.0003
140 METASTASES TO LUNG 3 0.0003
141 BACTERAEMIA 3 0.0003
142 PATENT DUCTUS ARTERIOSUS 1 0.0003
143 BLEPHARITIS 1 0.0002
144 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
145 SECOND PRIMARY MALIGNANCY 2 0.0002
146 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
147 AORTIC VALVE INCOMPETENCE 1 0.0002
148 PREMATURE BABY 7 0.0002
149 MYOPATHY 2 0.0002
150 PHYSICAL DISABILITY 1 0.0002
151 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
152 CHRONIC MYELOID LEUKAEMIA 1 0.0002
153 SKIN ABRASION 1 0.0002
154 CARDIAC TAMPONADE 1 0.0002
155 PRE-ECLAMPSIA 1 0.0002
156 TUMOUR MARKER INCREASED 1 0.0002
157 BREATH SOUNDS ABNORMAL 1 0.0002
158 ORGANISING PNEUMONIA 1 0.0002
159 SMALL FOR DATES BABY 1 0.0002
160 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
161 TRISMUS 1 0.0002
162 FAILURE TO THRIVE 1 0.0002
163 ANAL ABSCESS 1 0.0002
164 METASTASES TO BONE 3 0.0002
165 INTERMENSTRUAL BLEEDING 1 0.0002
166 ABORTION SPONTANEOUS 7 0.0002
167 VENTRICULAR SEPTAL DEFECT 1 0.0002
168 EXERCISE TOLERANCE DECREASED 1 0.0002
169 MOUTH SWELLING 1 0.0002
170 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
171 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
172 HYPERLIPIDAEMIA 2 0.0002
173 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
174 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
175 CHOLANGITIS 1 0.0002
176 HYPOGAMMAGLOBULINAEMIA 1 0.0002
177 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
178 BLOOD TESTOSTERONE DECREASED 1 0.0001
179 RESPIRATION ABNORMAL 1 0.0001
180 METASTASIS 1 0.0001
181 DERMATITIS BULLOUS 1 0.0001
182 HAEMOLYSIS 1 0.0001
183 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
184 PRODUCT USE COMPLAINT 2 0.0001
185 TRICUSPID VALVE INCOMPETENCE 1 0.0001
186 ASPHYXIA 1 0.0001
187 SENSATION OF FOREIGN BODY 1 0.0001
188 VITAMIN D DECREASED 1 0.0001
189 BLOOD CALCIUM INCREASED 1 0.0001
190 ISCHAEMIC STROKE 2 0.0001
191 FACIAL PAIN 1 0.0001
192 ANAL INCONTINENCE 1 0.0001
193 PULMONARY FIBROSIS 2 0.0001
194 SINUS BRADYCARDIA 1 0.0001
195 PARKINSONISM 1 0.0001
196 PHARYNGEAL SWELLING 1 0.0001
197 HEPATOMEGALY 1 0.0001
198 VITREOUS FLOATERS 1 0.0001
199 BODY TEMPERATURE DECREASED 1 0.0001
200 EAR DISCOMFORT 1 0.0001
201 POOR VENOUS ACCESS 1 0.0001
202 BREAST PAIN 1 0.0001
203 DECREASED ACTIVITY 1 0.0001
204 ASPIRATION 1 0.0001
205 MITRAL VALVE INCOMPETENCE 1 0.0001
206 SCAB 1 0.0001
207 MYOCARDITIS 1 0.0001
208 SPINAL PAIN 1 0.0001
209 ATAXIA 1 0.0001
210 THYROID CANCER 1 0.0001
211 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
212 DYSPNOEA EXERTIONAL 3 0.0001
213 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
214 TACHYCARDIA 7 0.0001
215 ANAPHYLACTIC SHOCK 2 0.0001
216 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
217 BEDRIDDEN 1 0.0001
218 SARS-COV-2 TEST POSITIVE 1 0.0001
219 QUALITY OF LIFE DECREASED 1 0.0001
220 SINUS CONGESTION 1 0.0001
221 NEUROPATHY PERIPHERAL 7 0.0001
222 TACHYPNOEA 1 0.0001
223 MASS 1 0.0001
224 ANOSMIA 1 0.0001
225 HYPOKINESIA 1 0.0001
226 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
227 ACUTE MYOCARDIAL INFARCTION 2 0.0001
228 PULMONARY MASS 1 0.0001
229 LACRIMATION INCREASED 2 0.0001
230 ECONOMIC PROBLEM 1 0.0001
231 THYROID DISORDER 1 0.0001
232 EJECTION FRACTION DECREASED 1 0.0001
233 THERAPY PARTIAL RESPONDER 1 0.0001
234 PREMATURE DELIVERY 1 0.0001
235 OBESITY 1 0.0001
236 EOSINOPHILIA 1 0.0001
237 METASTASES TO LIVER 1 0.0001
238 LYMPHADENOPATHY 2 0.0001
239 THIRST 1 0.0001
240 HEPATIC STEATOSIS 1 0.0001
241 BLOOD SODIUM DECREASED 1 0.0001
242 HYPOCALCAEMIA 1 0.0001
243 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
244 ORAL HERPES 1 0.0001
245 KIDNEY INFECTION 1 0.0001
246 DISABILITY 1 0.0001
247 PRODUCT PHYSICAL ISSUE 1 0.0000
248 FEEDING DISORDER 1 0.0000
249 TASTE DISORDER 1 0.0000
250 BONE MARROW FAILURE 1 0.0000
251 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
252 PRODUCT PREPARATION ERROR 1 0.0000
253 TREATMENT FAILURE 4 0.0000
254 CARDIO-RESPIRATORY ARREST 2 0.0000
255 HALLUCINATION, VISUAL 1 0.0000
256 SWELLING FACE 3 0.0000
257 PANCREATITIS ACUTE 1 0.0000
258 TINNITUS 2 0.0000
259 PERICARDIAL EFFUSION 1 0.0000
260 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
261 RESPIRATORY FAILURE 3 0.0000
262 ATRIAL FIBRILLATION 4 0.0000
263 CEREBRAL INFARCTION 1 0.0000
264 AGEUSIA 1 0.0000
265 UNRESPONSIVE TO STIMULI 1 0.0000
266 RASH GENERALISED 1 0.0000
267 DIPLOPIA 1 0.0000
268 JAUNDICE 1 0.0000
269 BLOOD BILIRUBIN INCREASED 1 0.0000
270 RESPIRATORY DISTRESS 1 0.0000
271 DIVERTICULITIS 1 0.0000
272 NECK PAIN 2 0.0000
273 PANCYTOPENIA 2 0.0000
274 PAIN IN JAW 1 0.0000
275 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
276 DYSPHONIA 2 0.0000
277 EMOTIONAL DISTRESS 4 0.0000
278 DISCOMFORT 2 0.0000
279 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
280 EMOTIONAL DISORDER 1 0.0000
281 GYNAECOMASTIA 1 0.0000
282 DRUG-INDUCED LIVER INJURY 1 0.0000
283 CYSTITIS 1 0.0000
284 MOVEMENT DISORDER 1 0.0000
285 BLOOD CREATININE INCREASED 2 0.0000
286 FEBRILE NEUTROPENIA 2 0.0000
287 VIRAL INFECTION 1 0.0000
288 FUNGAL INFECTION 1 0.0000
289 GAIT INABILITY 1 0.0000
290 HAEMATURIA 1 0.0000
291 HEART RATE DECREASED 1 0.0000
292 HYPOXIA 1 0.0000
293 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
294 PALPITATIONS 3 0.0000
295 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
296 BLINDNESS 1 0.0000
297 NEUTROPHIL COUNT DECREASED 1 0.0000
298 HYPERHIDROSIS 3 0.0000
299 LIVER DISORDER 1 0.0000
300 THROAT IRRITATION 1 0.0000
301 BLOOD CHOLESTEROL INCREASED 1 0.0000
302 BLOOD GLUCOSE INCREASED 4 0.0000
303 DYSPHAGIA 2 0.0000
304 PRODUCTIVE COUGH 1 0.0000
305 LUNG DISORDER 1 0.0000
306 DYSPEPSIA 2 0.0000
307 HEART RATE INCREASED 2 0.0000
308 FLUSHING 2 0.0000
309 CHEST DISCOMFORT 2 0.0000
310 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
311 INFLAMMATION 1 0.0000
312 MUSCULOSKELETAL PAIN 1 0.0000
313 PARAESTHESIA 3 0.0000
314 HYPERTENSION 4 0.0000
315 BRADYCARDIA 1 0.0000
316 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
317 DISTURBANCE IN ATTENTION 1 0.0000
318 PNEUMONIA 6 0.0000
319 RASH PRURITIC 1 0.0000
320 TREATMENT NONCOMPLIANCE 1 0.0000
321 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
322 TREMOR 3 0.0000
323 BLISTER 1 0.0000
324 EYE PAIN 1 0.0000
325 BACK PAIN 4 0.0000
326 ABDOMINAL PAIN 4 0.0000
327 NASAL CONGESTION 1 0.0000
328 SUICIDE ATTEMPT 1 0.0000
329 STOMATITIS 1 0.0000
330 FEELING HOT 1 0.0000
331 INTENTIONAL OVERDOSE 1 0.0000
332 RHINORRHOEA 1 0.0000
333 AMNESIA 1 0.0000
334 HEPATIC ENZYME INCREASED 1 0.0000
335 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
336 PYREXIA 5 0.0000
337 INJURY 1 0.0000
338 ANXIETY 4 0.0000
339 MOBILITY DECREASED 1 0.0000
340 UNDERDOSE 1 0.0000
341 DYSGEUSIA 1 0.0000
342 WEIGHT INCREASED 3 0.0000
343 HYPOAESTHESIA 2 0.0000
344 HALLUCINATION 1 0.0000
345 UNEVALUABLE EVENT 1 0.0000
346 PRURITUS 5 0.0000
347 OFF LABEL USE 11 0.0000
348 INJECTION SITE HAEMORRHAGE 1 0.0000
349 CARDIAC FAILURE 1 0.0000
350 CARDIAC FAILURE CONGESTIVE 1 0.0000
351 DRY MOUTH 1 0.0000
352 ABDOMINAL DISCOMFORT 2 0.0000
353 RENAL IMPAIRMENT 1 0.0000
354 BALANCE DISORDER 1 0.0000
355 FATIGUE 9 0.0000
356 RASH 5 0.0000
357 COVID-19 2 0.0000
358 GASTROINTESTINAL DISORDER 1 0.0000
359 OROPHARYNGEAL PAIN 1 0.0000
360 CHEST PAIN 2 0.0000
361 WEIGHT DECREASED 3 0.0000
362 CARDIAC DISORDER 1 0.0000
363 ASTHENIA 4 0.0000
364 VOMITING 5 0.0000
365 PULMONARY EMBOLISM 1 0.0000
366 GAIT DISTURBANCE 2 0.0000
367 CONTUSION 1 0.0000
368 ALOPECIA 2 0.0000
369 PAIN IN EXTREMITY 3 0.0000
370 NAUSEA 8 0.0000
371 HYPOTENSION 2 0.0000
372 CONDITION AGGRAVATED 3 0.0000
373 SINUSITIS 1 0.0000
374 ERYTHEMA 2 0.0000
375 ABDOMINAL DISTENSION 1 0.0000
376 HEADACHE 6 0.0000
377 DRUG INEFFECTIVE 12 0.0000
378 MUSCULAR WEAKNESS 1 0.0000
379 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
380 DECREASED APPETITE 2 0.0000
381 CHILLS 1 0.0000
382 DISEASE PROGRESSION 1 0.0000
383 FEELING ABNORMAL 2 0.0000
384 OEDEMA PERIPHERAL 1 0.0000
385 DRY SKIN 1 0.0000
386 NEUTROPENIA 1 0.0000
387 VISION BLURRED 1 0.0000
388 MEMORY IMPAIRMENT 1 0.0000
389 DYSPNOEA 4 0.0000
390 MALAISE 3 0.0000
391 PRODUCT DOSE OMISSION ISSUE 2 0.0000
392 HOSPITALISATION 1 0.0000
393 DIARRHOEA 4 0.0000
394 URTICARIA 1 0.0000
395 MYALGIA 1 0.0000
396 MYOCARDIAL INFARCTION 1 0.0000
397 MUSCLE SPASMS 1 0.0000
398 NASOPHARYNGITIS 1 0.0000
399 HYPERSENSITIVITY 1 0.0000
400 PRODUCT USE ISSUE 1 0.0000
401 SOMNOLENCE 1 0.0000
402 PAIN 3 0.0000
403 ABDOMINAL PAIN UPPER 1 0.0000
404 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
405 DIZZINESS 2 0.0000
406 INSOMNIA 1 0.0000
407 COUGH 1 0.0000
408 INJECTION SITE PAIN 1 0.0000
409 FALL 1 0.0000
410 ARTHRALGIA 1 0.0000
411 DEATH 2 0.0000